stoxline Quote Chart Rank Option Currency Glossary
  
Amarin Corporation plc (AMRN)
0.8908  0.002 (0.18%)    03-28 16:00
Open: 0.88
High: 0.91
Volume: 1,153,048
  
Pre. Close: 0.8892
Low: 0.88
Market Cap: 364(M)
Technical analysis
2024-03-28 4:49:40 PM
Short term     
Mid term     
Targets 6-month :  1.33 1-year :  1.58
Resists First :  1.14 Second :  1.36
Pivot price 0.86
Supports First :  0.8 Second :  0.66
MAs MA(5) :  0.86 MA(20) :  0.89
MA(100) :  0.96 MA(250) :  1.05
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  48.6 D(3) :  37.5
RSI RSI(14): 42.8
52-week High :  1.54 Low :  0.64
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ AMRN ] has closed below upper band by 28.9%. Bollinger Bands are 62.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.91 - 0.92 0.92 - 0.92
Low: 0.87 - 0.87 0.87 - 0.88
Close: 0.88 - 0.89 0.89 - 0.9
Company Description

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Headline News

Mon, 25 Mar 2024
Research Analysts Set Expectations for Amarin Co. plc's Q1 2024 Earnings (NASDAQ:AMRN) - MarketBeat

Tue, 12 Mar 2024
Little Excitement Around Amarin Corporation plc's (NASDAQ:AMRN) Revenues As Shares Take 27% Pounding - Simply Wall St

Fri, 01 Mar 2024
Amarin Corporation plc (NASDAQ:AMRN) Q4 2023 Earnings Call Transcript - Yahoo Finance

Thu, 29 Feb 2024
Amarin Corp PLC (AMRN) Faces Revenue Decline Amidst Generic Competition - Yahoo Finance

Thu, 29 Feb 2024
Amarin Corporation Plc's New Competition Risk – A Cause for Worry? - TipRanks.com - TipRanks

Thu, 29 Feb 2024
Amarin Corporation plc (AMRN) Q4 2023 Earnings Call Transcript - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 401 (M)
Shares Float 383 (M)
Held by Insiders 1.5 (%)
Held by Institutions 23.7 (%)
Shares Short 16,990 (K)
Shares Short P.Month 14,400 (K)
Stock Financials
EPS -0.16
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.35
Profit Margin -19.3 %
Operating Margin -6.2 %
Return on Assets (ttm) -1.3 %
Return on Equity (ttm) -10.4 %
Qtrly Rev. Growth -17.3 %
Gross Profit (p.s.) 0
Sales Per Share 0.76
EBITDA (p.s.) -0.04
Qtrly Earnings Growth 0 %
Operating Cash Flow 7 (M)
Levered Free Cash Flow -19 (M)
Stock Valuations
PE Ratio -5.94
PEG Ratio -0.2
Price to Book value 0.65
Price to Sales 1.16
Price to Cash Flow 51.96
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android